Cargando…

Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma

Liver cancer is a leading cause of cancer-associated mortality worldwide. Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. The aim of the present study was to identify long non-coding RNA (lncRNAs) as diagnostic biomarkers for HCC. The lncRNA and mRNA expression profiles of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Gang, Shi, Hao, Wang, Xinyi, Wang, Bei, Qu, Qianqian, Geng, Haiyang, Sun, Hongjun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625424/
https://www.ncbi.nlm.nih.gov/pubmed/31173205
http://dx.doi.org/10.3892/mmr.2019.10307
_version_ 1783434414266515456
author Li, Gang
Shi, Hao
Wang, Xinyi
Wang, Bei
Qu, Qianqian
Geng, Haiyang
Sun, Hongjun
author_facet Li, Gang
Shi, Hao
Wang, Xinyi
Wang, Bei
Qu, Qianqian
Geng, Haiyang
Sun, Hongjun
author_sort Li, Gang
collection PubMed
description Liver cancer is a leading cause of cancer-associated mortality worldwide. Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. The aim of the present study was to identify long non-coding RNA (lncRNAs) as diagnostic biomarkers for HCC. The lncRNA and mRNA expression profiles of a large group of patients with HCC were obtained from The Cancer Genome Atlas. The differentially expressed lncRNAs (DElncRNAs) and the differentially expressed mRNAs (DEmRNAs) were identified by bioinformatics analysis. Using feature selection procedure and a classification model, the optimal diagnostic lncRNA biomarkers for HCC were identified. Classification models, including random forests, decision tree and support vector machine (SVM), were established to distinguish between HCC and normal tissues. DEmRNAs co-expressed with the lncRNAs were considered as targets of DElncRNAs. Functional annotation of DEmRNAs co-expressed with these lncRNAs biomarkers was performed. Receiver operating characteristic curve analysis of lncRNAs biomarkers was conducted. A total of 3,177 lncRNAs and 15,183 mRNAs between HCC and normal tissues were obtained. RP11-486O12.2, RP11-863K10.7, LINC01093 and RP11-273G15.2 were identified as optimal diagnostic lncRNA biomarkers for HCC that were co-expressed with 273, 69, 76 and 1 DEmRNAs, respectively. The area under the curve values of the random forest model, decision tree model and SVM model were 0.992, 0.927 and 0.992, and the specificity and sensitivity of the three models were 100.0 and 95.6, 92.0 and 98.3 and 98.0 and 97.2%, respectively. ‘PPAR signaling pathway’ and ‘retinol metabolism’ were two significantly enriched target pathways of DElncRNAs. The present study identified four DElncRNAs, including RP11-486O12.2, RP11-863K10.7, LINC01093 and RP11-273G15.2, as potential diagnostic biomarkers of HCC. Functional annotation of target DEmRNAs provided novel evidence for examining the precise roles of lncRNA in HCC.
format Online
Article
Text
id pubmed-6625424
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-66254242019-07-31 Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma Li, Gang Shi, Hao Wang, Xinyi Wang, Bei Qu, Qianqian Geng, Haiyang Sun, Hongjun Mol Med Rep Articles Liver cancer is a leading cause of cancer-associated mortality worldwide. Hepatocellular carcinoma (HCC) is the most common subtype of liver cancer. The aim of the present study was to identify long non-coding RNA (lncRNAs) as diagnostic biomarkers for HCC. The lncRNA and mRNA expression profiles of a large group of patients with HCC were obtained from The Cancer Genome Atlas. The differentially expressed lncRNAs (DElncRNAs) and the differentially expressed mRNAs (DEmRNAs) were identified by bioinformatics analysis. Using feature selection procedure and a classification model, the optimal diagnostic lncRNA biomarkers for HCC were identified. Classification models, including random forests, decision tree and support vector machine (SVM), were established to distinguish between HCC and normal tissues. DEmRNAs co-expressed with the lncRNAs were considered as targets of DElncRNAs. Functional annotation of DEmRNAs co-expressed with these lncRNAs biomarkers was performed. Receiver operating characteristic curve analysis of lncRNAs biomarkers was conducted. A total of 3,177 lncRNAs and 15,183 mRNAs between HCC and normal tissues were obtained. RP11-486O12.2, RP11-863K10.7, LINC01093 and RP11-273G15.2 were identified as optimal diagnostic lncRNA biomarkers for HCC that were co-expressed with 273, 69, 76 and 1 DEmRNAs, respectively. The area under the curve values of the random forest model, decision tree model and SVM model were 0.992, 0.927 and 0.992, and the specificity and sensitivity of the three models were 100.0 and 95.6, 92.0 and 98.3 and 98.0 and 97.2%, respectively. ‘PPAR signaling pathway’ and ‘retinol metabolism’ were two significantly enriched target pathways of DElncRNAs. The present study identified four DElncRNAs, including RP11-486O12.2, RP11-863K10.7, LINC01093 and RP11-273G15.2, as potential diagnostic biomarkers of HCC. Functional annotation of target DEmRNAs provided novel evidence for examining the precise roles of lncRNA in HCC. D.A. Spandidos 2019-08 2019-05-28 /pmc/articles/PMC6625424/ /pubmed/31173205 http://dx.doi.org/10.3892/mmr.2019.10307 Text en Copyright: © Li et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Li, Gang
Shi, Hao
Wang, Xinyi
Wang, Bei
Qu, Qianqian
Geng, Haiyang
Sun, Hongjun
Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
title Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
title_full Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
title_fullStr Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
title_full_unstemmed Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
title_short Identification of diagnostic long non-coding RNA biomarkers in patients with hepatocellular carcinoma
title_sort identification of diagnostic long non-coding rna biomarkers in patients with hepatocellular carcinoma
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625424/
https://www.ncbi.nlm.nih.gov/pubmed/31173205
http://dx.doi.org/10.3892/mmr.2019.10307
work_keys_str_mv AT ligang identificationofdiagnosticlongnoncodingrnabiomarkersinpatientswithhepatocellularcarcinoma
AT shihao identificationofdiagnosticlongnoncodingrnabiomarkersinpatientswithhepatocellularcarcinoma
AT wangxinyi identificationofdiagnosticlongnoncodingrnabiomarkersinpatientswithhepatocellularcarcinoma
AT wangbei identificationofdiagnosticlongnoncodingrnabiomarkersinpatientswithhepatocellularcarcinoma
AT quqianqian identificationofdiagnosticlongnoncodingrnabiomarkersinpatientswithhepatocellularcarcinoma
AT genghaiyang identificationofdiagnosticlongnoncodingrnabiomarkersinpatientswithhepatocellularcarcinoma
AT sunhongjun identificationofdiagnosticlongnoncodingrnabiomarkersinpatientswithhepatocellularcarcinoma